These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 22465937)
21. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. Komatsu T; Yamazaki H; Shimada N; Nakajima M; Yokoi T Drug Metab Dispos; 2000 Dec; 28(12):1457-63. PubMed ID: 11095583 [TBL] [Abstract][Full Text] [Related]
22. Preferential metabolic activation of N-nitrosopiperidine as compared to its structural homologue N-nitrosopyrrolidine by rat nasal mucosal microsomes. Wong HL; Murphy SE; Hecht SS Chem Res Toxicol; 2003 Oct; 16(10):1298-305. PubMed ID: 14565771 [TBL] [Abstract][Full Text] [Related]
23. Nicotine 5'-oxidation and methyl oxidation by P450 2A enzymes. Murphy SE; Raulinaitis V; Brown KM Drug Metab Dispos; 2005 Aug; 33(8):1166-73. PubMed ID: 15860657 [TBL] [Abstract][Full Text] [Related]
24. 3'-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression. Wang J; Pitarque M; Ingelman-Sundberg M Biochem Biophys Res Commun; 2006 Feb; 340(2):491-7. PubMed ID: 16378601 [TBL] [Abstract][Full Text] [Related]
25. Metabolism of methyl tert-butyl ether and other gasoline ethers by human liver microsomes and heterologously expressed human cytochromes P450: identification of CYP2A6 as a major catalyst. Hong JY; Wang YY; Bondoc FY; Lee M; Yang CS; Hu WY; Pan J Toxicol Appl Pharmacol; 1999 Oct; 160(1):43-8. PubMed ID: 10502501 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Draper AJ; Madan A; Parkinson A Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of stereospecifically deuterated 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) iastereomers and metabolism by A/J mouse lung microsomes and cytochrome p450 2A5. Jalas JR; Hecht SS Chem Res Toxicol; 2003 Jun; 16(6):782-93. PubMed ID: 12807362 [TBL] [Abstract][Full Text] [Related]
28. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system. Tan Y; Patten CJ; Smith T; Yang CS Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616 [TBL] [Abstract][Full Text] [Related]
29. CYP2A6 AND CYP2B6 are involved in nornicotine formation from nicotine in humans: interindividual differences in these contributions. Yamanaka H; Nakajima M; Fukami T; Sakai H; Nakamura A; Katoh M; Takamiya M; Aoki Y; Yokoi T Drug Metab Dispos; 2005 Dec; 33(12):1811-8. PubMed ID: 16135656 [TBL] [Abstract][Full Text] [Related]
30. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1. Bu HZ; Magis L; Knuth K; Teitelbaum P Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532 [TBL] [Abstract][Full Text] [Related]
31. Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes. DeVore NM; Smith BD; Urban MJ; Scott EE Drug Metab Dispos; 2008 Dec; 36(12):2582-90. PubMed ID: 18779312 [TBL] [Abstract][Full Text] [Related]
32. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Nakajima M; Yamamoto T; Nunoya K; Yokoi T; Nagashima K; Inoue K; Funae Y; Shimada N; Kamataki T; Kuroiwa Y Drug Metab Dispos; 1996 Nov; 24(11):1212-7. PubMed ID: 8937855 [TBL] [Abstract][Full Text] [Related]
33. Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro. Ikeda K; Yoshisue K; Matsushima E; Nagayama S; Kobayashi K; Tyson CA; Chiba K; Kawaguchi Y Clin Cancer Res; 2000 Nov; 6(11):4409-15. PubMed ID: 11106261 [TBL] [Abstract][Full Text] [Related]
34. Modified nicotine metabolism in transgenic tobacco plants expressing the human cytochrome P450 2A6 cDNA. Dueckershoff K; Unger M; Frank A; Gillam EM; Guengerich FP; Warzecha H FEBS Lett; 2005 Apr; 579(11):2480-4. PubMed ID: 15848192 [TBL] [Abstract][Full Text] [Related]
35. Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme--an in silico approach. Rahnasto M; Wittekindt C; Juvonen RO; Turpeinen M; Petsalo A; Pelkonen O; Poso A; Stahl G; Höltje HD; Raunio H Pharmacogenomics J; 2008 Oct; 8(5):328-38. PubMed ID: 17923852 [TBL] [Abstract][Full Text] [Related]
36. Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and mice. Siu EC; Tyndale RF J Pharmacol Exp Ther; 2008 Mar; 324(3):992-9. PubMed ID: 18065502 [TBL] [Abstract][Full Text] [Related]
37. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1. Duescher RJ; Elfarra AA Arch Biochem Biophys; 1994 Jun; 311(2):342-9. PubMed ID: 8203896 [TBL] [Abstract][Full Text] [Related]
38. Multiple-ligand binding in CYP2A6: probing mechanisms of cytochrome P450 cooperativity by assessing substrate dynamics. Harrelson JP; Atkins WM; Nelson SD Biochemistry; 2008 Mar; 47(9):2978-88. PubMed ID: 18247580 [TBL] [Abstract][Full Text] [Related]
39. Functional characterization of cytochrome P450 2A6 allelic variants CYP2A6*15, CYP2A6*16, CYP2A6*21, and CYP2A6*22. Tiong KH; Yiap BC; Tan EL; Ismail R; Ong CE Drug Metab Dispos; 2010 May; 38(5):745-51. PubMed ID: 20139165 [TBL] [Abstract][Full Text] [Related]
40. Novel sensitive high-performance liquid chromatographic method for assay of coumarin 7-hydroxylation. Soucek P J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):23-9. PubMed ID: 10574186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]